What is the difference between METFORMIN ER 500 MG and PIOGLITAZONE HCL AND METFORMIN HCL?

METFORMIN ER 500 MG and PIOGLITAZONE HCL AND METFORMIN HCL are both Biguanides, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is Metformin the same as Pioglitazone HCL and Metformin HCL?

No. Metformin (METFORMIN ER 500 MG) and Pioglitazone HCL and Metformin HCL (PIOGLITAZONE HCL AND METFORMIN HCL) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, METFORMIN ER 500 MG or PIOGLITAZONE HCL AND METFORMIN HCL?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from METFORMIN ER 500 MG to PIOGLITAZONE HCL AND METFORMIN HCL?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

METFORMIN ER 500 MG vs PIOGLITAZONE HCL AND METFORMIN HCL

Compare METFORMIN ER 500 MG (Metformin) and PIOGLITAZONE HCL AND METFORMIN HCL (Pioglitazone HCL and Metformin HCL) — clinical data, side effects, and patient experiences.

METFORMIN ER 500 MG

Metformin, Jentadueto XR · Biguanide

How it works

Other agent

Approved for

INDICATIONS & USAGE Metformin hydrochloride extended-release tablets

USP are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

OralTablet

PIOGLITAZONE HCL AND METFORMIN HCL

Pioglitazone HCL and Metformin HCL · Biguanide

How it works

12.1 Mechanism of Action Pioglitazone and metformin hydrochloride tablets combine two antihyperglycemic agents: pioglitazone and metformin. Pioglitazone Pioglitazone is a thiazolid...

Approved for

1 INDICATIONS AND USAGE Pioglitazone and metformin hydrochloride tablets

are a combination of pioglitazone

a thiazolidinedione agonist of peroxisome proliferator receptor gamma

and metformin hydrochloride (HCl)

OralTablet

Quick Comparison

METFORMIN ER 500 MGPIOGLITAZONE HCL AND METFORMIN HCL

Drug Class

Biguanide

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

METFORMIN ER 500 MG

Nausea

>10%

Diarrhea

1-10%

Drug Not Working

1-10%

Fatigue

1-10%

Vomiting

1-10%

Weight Loss

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

PIOGLITAZONE HCL AND METFORMIN HCL

Nausea

1-10%

Weight Loss

1-10%

Diarrhea

1-10%

Drug Not Working

0.1-1%

Fatigue

0.1-1%

Shortness of Breath

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

FDA Warnings

METFORMIN ER 500 MG

WARNINGS LACTIC ACIDOSIS: Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension and resistant bradyarrhythmias
Risk factors for metformin associated lactic acidosis include renal impairment, concamitent use of certain drugs (e
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided (see DOSAGE AND ADMINISTRATION , CONTRAINDICATIONS , AND PRECAUTIONS )

PIOGLITAZONE HCL AND METFORMIN HCL

5 WARNINGS AND PRECAUTIONS • Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure
Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk
3 ) • Hypoglycemia: Consider a lower dose of insulin or insulin secretagogue to reduce risk of hypoglycemia when used in combination with pioglitazone and metformin hydrochloride tablets
4 ) • Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal

Clinical Trial Data

No head-to-head clinical studies found for METFORMIN ER 500 MG vs PIOGLITAZONE HCL AND METFORMIN HCL.

METFORMIN ER 500 MG vs PIOGLITAZONE HCL AND METFORMIN HCL: What You Should Know

Key Differences

Both METFORMIN ER 500 MG and PIOGLITAZONE HCL AND METFORMIN HCL belong to the Biguanide class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

METFORMIN ER 500 MG carries 3 FDA warnings. PIOGLITAZONE HCL AND METFORMIN HCL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Metformin vs METFORMIN ER 500 MG→Metformin vs PIOGLITAZONE HCL AND METFORMIN HCL→METFORMIN ER 500 MG vs METFORMIN HCL→METFORMIN ER 500 MG vs METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS→METFORMIN ER 500 MG vs METFORMIN HYDROCHLORIDE TABLETS→METFORMIN ER 500 MG vs METFORMIN HYDROCHLORIDE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

METFORMIN ER 500 MG: DailyMed label · FAERS adverse events · ClinicalTrials.gov
PIOGLITAZONE HCL AND METFORMIN HCL: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

METFORMIN ER 500 MG vs PIOGLITAZONE HCL AND METFORMIN HCL

Compare METFORMIN ER 500 MG (Metformin) and PIOGLITAZONE HCL AND METFORMIN HCL (Pioglitazone HCL and Metformin HCL) — clinical data, side effects, and patient experiences.

METFORMIN ER 500 MG

Metformin, Jentadueto XR · Biguanide

How it works

Other agent

Approved for

INDICATIONS & USAGE Metformin hydrochloride extended-release tablets

USP are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

OralTablet

PIOGLITAZONE HCL AND METFORMIN HCL

Pioglitazone HCL and Metformin HCL · Biguanide

How it works

12.1 Mechanism of Action Pioglitazone and metformin hydrochloride tablets combine two antihyperglycemic agents: pioglitazone and metformin. Pioglitazone Pioglitazone is a thiazolid...

Approved for

1 INDICATIONS AND USAGE Pioglitazone and metformin hydrochloride tablets

are a combination of pioglitazone

a thiazolidinedione agonist of peroxisome proliferator receptor gamma

and metformin hydrochloride (HCl)

OralTablet

Quick Comparison

METFORMIN ER 500 MGPIOGLITAZONE HCL AND METFORMIN HCL

Drug Class

Biguanide

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

METFORMIN ER 500 MG

Nausea

>10%

Diarrhea

1-10%

Drug Not Working

1-10%

Fatigue

1-10%

Vomiting

1-10%

Weight Loss

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

PIOGLITAZONE HCL AND METFORMIN HCL

Nausea

1-10%

Weight Loss

1-10%

Diarrhea

1-10%

Drug Not Working

0.1-1%

Fatigue

0.1-1%

Shortness of Breath

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

FDA Warnings

METFORMIN ER 500 MG

WARNINGS LACTIC ACIDOSIS: Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension and resistant bradyarrhythmias
Risk factors for metformin associated lactic acidosis include renal impairment, concamitent use of certain drugs (e
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided (see DOSAGE AND ADMINISTRATION , CONTRAINDICATIONS , AND PRECAUTIONS )

PIOGLITAZONE HCL AND METFORMIN HCL

5 WARNINGS AND PRECAUTIONS • Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure
Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk
3 ) • Hypoglycemia: Consider a lower dose of insulin or insulin secretagogue to reduce risk of hypoglycemia when used in combination with pioglitazone and metformin hydrochloride tablets
4 ) • Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal

Clinical Trial Data

No head-to-head clinical studies found for METFORMIN ER 500 MG vs PIOGLITAZONE HCL AND METFORMIN HCL.

METFORMIN ER 500 MG vs PIOGLITAZONE HCL AND METFORMIN HCL: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

METFORMIN ER 500 MG: DailyMed label · FAERS adverse events · ClinicalTrials.gov
PIOGLITAZONE HCL AND METFORMIN HCL: DailyMed label · FAERS adverse events · ClinicalTrials.gov